Skip to content

Pharmacology, Biochemistry, and Behavior

ISSN 1873-5177, 0091-3057

325 papers in the library · 3,738 citations · publishing 1975-2026

Papers

Sort Most recent Most cited

Effects of anandamide administration on components of reward processing during free choice.

Pharmacology, Biochemistry, and Behavior July 2017 Luke C Zona, Benjamin R Fry, Jacob A LaLonde et al.

Previous research has implicated the positive modulation of anandamide, an endocannabinoid neurotransmitter, on feeding behavior. Anandamide is particularly noteworthy as it acts as an endogenous ligand of the CB1 receptor, the same receptor that is activated by tetrahydrocannabinol, the primary psychoactive component in Cannabis sativa. Cannabis legalization in North America has presented with...

DOI: 10.1016/j.pbb.2017.05.008 (opens in new tab) Full text (opens in new tab) Anandamide Decision-making Endocannabinoids Incentive contrast +1

Differences between adolescents and adults in the acute effects of PCP and ketamine and in sensitization following intermittent administration.

Pharmacology, Biochemistry, and Behavior June 1, 2017 Angelica Rocha, Nigel Hart, Keith A Trujillo

Adolescence is a phase of development during which many physiological and behavioral changes occur, including increased novelty seeking and risk taking. In humans, this is reflected in experimentation with drugs. Research demonstrates that drug use that begins during adolescence is more likely to lead to addiction than drug use that begins later in life. Despite this, relatively little is known...

Sex differences in the subjective effects of oral Δ9-THC in cannabis users.

Pharmacology, Biochemistry, and Behavior January 2017 Jessica S Fogel, Thomas H Kelly, Philip M Westgate et al.

Previous studies suggest that there are sex differences in endocannabinoid function and the response to exogenous cannabinoids, though data from clinical studies comparing acute cannabinoid effects in men and women under controlled laboratory conditions are limited. To further explore these potential differences, data from 30 cannabis users (N=18 M, 12 F) who completed previous...

Effects of the psychotomimetic benzomorphan N-allylnormetazocine (SKF 10,047) on prepulse inhibition of startle in mice.

Pharmacology, Biochemistry, and Behavior September 1, 2016 Adam L. Halberstadt, James Hyun, Michael A Ruderman et al.

N-allylnormetazocine (NANM; SKF 10,047) is a benzomorphan opioid that produces psychotomimetic effects. (+)-NANM is the prototypical agonist for the sigma-1 (σ1) receptor, and there is a widespread belief that the hallucinogenic effects of NANM and other benzomorphan derivatives are mediated by interactions with σ1 sites. However, NANM is also an agonist at the κ opioid receptor (KOR) and binds...

DOI: 10.1016/j.pbb.2016.05.009 (opens in new tab) Full text (opens in new tab) Dissociative Hallucinogen Kappa receptor Mice +3

Serotonin antagonists fail to alter MDMA self-administration in rats.

Pharmacology, Biochemistry, and Behavior September 2016 Susan Schenk, Jason Foote, Dane Aronsen et al.

Acute exposure to ±3,4-methylenedioxymethamphetamine (MDMA) preferentially increases release of serotonin (5-HT), and a role of 5-HT in many of the behavioral effects of acute exposure to MDMA has been demonstrated. A role of 5-HT in MDMA self-administration in rats has not, however, been adequately determined. Therefore, the present study measured the effect of pharmacological manipulation of...

DOI: 10.1016/j.pbb.2016.06.002 (opens in new tab) Full text (opens in new tab) MDMA Hyperactivity Reinstatement Self-administration +1

Sex Differences in Abuse-Related Neurochemical and Behavioral Effects of 3,4-methylenedioxymethamphetamine (MDMA) in Rats

Pharmacology, Biochemistry, and Behavior August 24, 2016 Matthew F. Lazenka, J. Suyama, Clayton T. Bauer et al.

ABSTRACT 3,4‐Methylenedioxymethamphetamine (MDMA) is a substrate for dopamine (DA), norepinephrine and serotonin (5HT) transporters that produces greater pharmacological effects on certain endpoints in females than males in both clinical and rodent preclinical studies. To evaluate potential for sex differences in abuse‐related MDMA effects, the present study compared MDMA effects on...

Delta-9-tetrahydrocannabinol (THC) history fails to affect THC's ability to induce place preferences in rats.

Pharmacology, Biochemistry, and Behavior May 2016 Briana J. Hempel, Alison Wakeford, Matthew M Clasen et al.

In pre-clinical models of marijuana abuse, there is relatively limited evidence of delta-9-tetrahydrocannabinol's (THC) rewarding effects, as indexed by its general inability to induce a place preference. One explanation for this failure is that its rewarding effects are masked by its concurrently occurring aversive properties. Consistent with this explanation, THC pre-exposure, which...

Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine.

Pharmacology, Biochemistry, and Behavior April 1, 2016 Adam L. Halberstadt 33 citations

Monoamine oxidase inhibitors (MAOIs) are often ingested together with tryptamine hallucinogens, but relatively little is known about the consequences of their combined use. We have shown previously that monoamine oxidase-A (MAO-A) inhibitors alter the locomotor profile of the hallucinogen 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in rats, and enhance its interaction with 5-HT2A receptors....

Acute oral 18-methoxycoronaridine (18-MC) decreases both alcohol intake and IV nicotine self-administration in rats.

Pharmacology, Biochemistry, and Behavior 2016 Amir H Rezvani, Marty C Cauley, Susan Slade et al. 22 citations

The ibogaine derivative 18-methoxycoronaridine (18-MC) has been found to decrease self-administration of morphine, nicotine and alcohol in rats after systemic injection. However oral dosing is the preferred route clinically. The current study evaluated the effect of oral 18-MC dosing in rats on alcohol and nicotine self-administration. For the nicotine study, young adult female Sprague-Dawley...

DOI: 10.1016/j.pbb.2016.10.010 (opens in new tab) Full text (opens in new tab) Alcohol preferring rat Drinking Addiction treatment Alcoholism research +2

MDMA ('Ecstasy'), oxytocin and vasopressin modulate social preference in rats: A role for handling and oxytocin receptors.

Pharmacology, Biochemistry, and Behavior 2016 Linnet Ramos, Callum Hicks, Alex Caminer et al.

In laboratory rats, peripheral administration of the neuropeptides oxytocin (OT) and vasopressin (AVP) induces similar prosocial effects (i.e. increased adjacent lying) to the party drug 3,4-methylenedioxymethamphetamine (MDMA), which are sensitive to vasopressin V1A receptor (V1AR) antagonism. Here, we employed a social preference paradigm to further compare the prosocial effects of OT, AVP...

Methoxetamine, a ketamine derivative, produced conditioned place preference and was self-administered by rats: Evidence of its abuse potential.

Pharmacology, Biochemistry, and Behavior June 1, 2015 Chrislean Jun Botanas, J. B. de la Peña, I. J. D. Dela Peña et al.

Methoxetamine (MXE) is an N-methyl-d-aspartate (NMDA) receptor antagonist that is chemically and pharmacologically similar to ketamine. Recently, there have been many reports regarding its use/misuse in humans which have resulted in serious or even fatal outcomes. Despite these reports, MXE is not controlled or regulated in many countries which may be partly due to the lack of scientific...

Cross-substitution of Δ9-tetrahydrocannabinol and JWH-018 in drug discrimination in rats.

Pharmacology, Biochemistry, and Behavior September 2014 Jenny L Wiley, Timothy W Lefever, Ricardo A Cortes et al.

Synthetic indole-derived cannabinoids, originally developed to probe cannabinoid CB1 and CB2 receptors, have become widely abused for their marijuana-like intoxicating properties. The present study examined the effects of indole-derived cannabinoids in rats trained to discriminate Δ(9)-tetrahydrocannabinol (Δ(9)-THC) from vehicle. In addition, the effects of Δ(9)-THC in rats trained to...

DOI: 10.1016/j.pbb.2014.05.016 (opens in new tab) Full text (opens in new tab) Discriminative stimulus Jwh-018 Jwh-073 Jwh-210 +2

Blunting of the HPA-axis underlies the lack of preventive efficacy of early post-stressor single-dose Delta-9-tetrahydrocannabinol (THC).

Pharmacology, Biochemistry, and Behavior July 2014 Tzur Alexander Mayer, Michael Alex Matar, Zeev Kaplan et al.

The therapeutic value of Delta-9-tetrahydrocannabinol (Δ9-THC) in the aftermath of trauma has recently raised interest. A prospective animal model for posttraumatic stress disorder was employed to assess the behavioral effects of a single dose of Δ9-THC administered intraperitoneally following exposure to psychogenic stress. Animals were exposed to predator scent stress and treated 1h later...

DOI: 10.1016/j.pbb.2014.04.014 (opens in new tab) Full text (opens in new tab) Animal model Cb1 antagonist/inverse agonist Delta-9-Tetrahydrocannabinol δ9-THC Early drug intervention +2

Acute administration of Δ⁹ tetrahydrocannabinol does not prevent enhancement of sensory gating by clozapine in DBA/2 mice.

Pharmacology, Biochemistry, and Behavior March 2014 Jason Smucny, Karen E Stevens, Jason R Tregellas

Despite high rates of marijuana abuse in schizophrenia, the physiological interactions between tetrahydrocannabinol (THC) and antipsychotic medications are poorly understood. A well-characterized feature of schizophrenia is poor gating of the P50 auditory-evoked potential. This feature has been translationally modeled by the DBA/2 mouse, which exhibits poor suppression of the P20-N40 AEP, the...

MDMA decreases the effects of simulated social rejection.

Pharmacology, Biochemistry, and Behavior February 2014 Charles G Frye, Margaret C. Wardle, Greg J Norman et al.

3-4-Methylenedioxymethamphetamine (MDMA) increases self-reported positive social feelings and decreases the ability to detect social threat in faces, but its effects on experiences of social acceptance and rejection have not been determined. We examined how an acute dose of MDMA affects subjective and autonomic responses to simulated social acceptance and rejection. We predicted that MDMA would...

DOI: 10.1016/j.pbb.2013.11.030 (opens in new tab) Full text (opens in new tab) MDMA Cyberball Respiratory sinus arrhythmia Social cognition

Chronic administration during early adulthood does not alter the hormonally-dependent disruptive effects of delta-9-tetrahydrocannabinol (Δ9-THC) on complex behavior in female rats.

Pharmacology, Biochemistry, and Behavior February 2014 Peter J Winsauer, Jessie L Sutton

This study examined whether chronic Δ(9)-THC during early adulthood would produce the same hormonally-dependent deficits in learning that are produced by chronic Δ(9)-THC during adolescence. To do this, either sham-operated (intact) or ovariectomized (OVX) female rats received daily saline or 5.6 mg/kg of Δ(9)-THC i.p. for 40 days during early adulthood. Following chronic administration, and a...

Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability.

Pharmacology, Biochemistry, and Behavior January 2013 Lesley D O'Brien, Kiri L Wills, Blair Segsworth et al.

The acute effects of cannabinoid compounds have been investigated in animal models of anxiety-like behavior and palatability processing. However, the chronic effects of cannabinoids in such models are poorly understood. Experiment 1 compared the effects of both acute and chronic (14 days) exposure to the CB(1) receptor inverse agonist/antagonist, rimonabant, and the cannabis-derived CB(1)...

Ovarian hormones and chronic administration during adolescence modify the discriminative stimulus effects of delta-9-tetrahydrocannabinol (Δ⁹-THC) in adult female rats.

Pharmacology, Biochemistry, and Behavior September 2012 Peter J Winsauer, Catalin M Filipeanu, Evangeline M Bailey et al.

Marijuana abuse during adolescence may alter its abuse liability during adulthood by modifying the interoceptive (discriminative) stimuli produced, especially in females due to an interaction with ovarian hormones. To examine this possibility, either gonadally intact or ovariectomized (OVX) female rats received 40 intraperitoneal injections of saline or 5.6 mg/kg of Δ⁹-THC daily during...

Pretreatment with Δ9-tetrahydrocannabinol (THC) increases cocaine-stimulated activity in adolescent but not adult male rats.

Pharmacology, Biochemistry, and Behavior January 2012 Diana Dow-Edwards, Sari Izenwasser

Marijuana (Cannabis sativa) remains one of the most widely used illegal drugs, with adolescents being particularly vulnerable to its use and abuse. In spite of this, most studies are conducted in adult animals even though the effects might be quite different in adolescents. Additionally, the use of marijuana often precedes the use of other psychoactive drugs including cocaine, especially when...

Modulatory effects of low-dose MDMA on cocaine-induced locomotor activity and place conditioning in rats.

Pharmacology, Biochemistry, and Behavior January 2012 John J Panos, Lisa E Baker

Methylenedioxymethamphetamine (MDMA; "Ecstasy") is commonly abused by humans in environments such as nightclubs and rave parties where other drugs of abuse are readily available. Despite the popularity of polysubstance abuse among recreational MDMA users, relatively few controlled experimental studies have documented the neurobehavioral effects of MDMA in combination with other abused...

Effect of ketamine on exploratory behaviour in BALB/C and C57BL/6 mice.

Pharmacology, Biochemistry, and Behavior January 2012 Kubra Akillioglu, Emine Babar Melik, Enver Melik et al.

In this study, we evaluated the effect of ketamine on exploratory locomotion behaviours in the Balb/c and C57BL/6 strains of mice, which differ in their locomotion behaviours. Intraperitoneal administration of ketamine at three different doses (1, 5 or 10 mg/kg, 0.1 ml/10 gr body weight) was performed on adult male Balb/c and C57BL/6 mice. The same volume of saline was applied to the control...

Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD)

Pharmacology, Biochemistry, and Behavior December 15, 2011 Emmanuelle A. D. Schindler, Kuldip D. Dave, Elaine M. Smolock et al. 18 citations

RationaleAfter decades of social stigma, hallucinogens have reappeared in the clinical literature demonstrating unique benefits in medicine. The precise behavioral pharmacology of these compounds remains unclear, however.ObjectivesTwo commonly studied hallucinogens, (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD), were investigated both in vivo and...

The effects of phencyclidine (PCP) on anxiety-like behavior in the elevated plus maze and the light-dark exploration test are age dependent, sexually dimorphic, and task dependent.

Pharmacology, Biochemistry, and Behavior November 1, 2011 Sarah M Turgeon, Daniel S. H. Kim, Melissa Pritchard et al.

Previous research in our laboratory revealed sexually dimorphic effects of prior exposure to phencyclidine (PCP) on elevated plus maze behavior. In an attempt to examine the developmental time course of this effect and determine the extent to which it generalizes to other anxiety paradigms, young adult (61-64 days old) and adult (96-107 days old) male and female rats were treated with PCP (15...

Acute blockade of CB1 receptor leads to reinstatement of MDMA-induced conditioned place preference.

Pharmacology, Biochemistry, and Behavior November 2011 Manuel Daza‐losada, José Miñarro, María A. Aguilar et al.

Cannabis is one of the drugs most commonly consumed in combination with ecstasy (3,4-methylenedioxymethamphetamine, MDMA). Although numerous studies have attempted to further our understanding of the role of the cannabinoid system in drug abuse, few have focused on how it influences the rewarding effects of MDMA. The aim of the present study was to evaluate the role of the CB1 cannabinoid...

MDMA: interactions with other psychoactive drugs.

Pharmacology, Biochemistry, and Behavior October 2011 Wael M.Y. Mohamed, Sami Ben Hamida, Jean-Christophe Cassel et al.

3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) is one of the most widely abused illegal drugs. Some users self-report euphoria and an increased perception and feeling of closeness to others. When taken in warm environments, MDMA users may develop acute complications with potential fatal consequences. In rodents, MDMA increases locomotor activity and, depending on ambient temperature, may...